Protéus by Seqens is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes.

Proteus offers :
 An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains)
 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes
 Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances
 A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications
 Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals
 A range of proprietary Bioproducts

Protéus is an affiliate of Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering custom-made products and solutions to its customers. Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production